PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 17.63% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 20.36% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, up 22.09% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.7 million, up from $1.7 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for PRCT reached as high as $1.7 million in Q1 2026 and fell as low as $642000.0 in Q2 2023.
• Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.3 million in 2024.
• Across the five-year window, Depreciation & Amortization (CF) dropped 17.16% in 2022 and jumped 98.79% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $663000.0 in 2022, then soared by 98.79% to $1.3 million in 2023, then grew by 10.24% to $1.5 million in 2024, then advanced by 17.62% to $1.7 million in 2025, then grew by 1.52% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.